RVMD
Revolution Medicines, Inc.
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied
Revolution Medicines, Inc.
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied
Revolution Medicines has 4 disclosed suppliers and 2 disclosed customers in SEC filings.
Revolution Medicines, Inc.
191.49
SentencePursuant to the Aethon Collaboration Agreement, we agreed to reimburse Aethon for preclinical activities, and we have an option to conduct any clinical or commercial development that may arise from the collaboration.
RVMD 10-Kaccession 0001193125-26-071563
SentenceOur warrants were issued in registered form under a Warrant Agreement between Continental Stock Transfer & Trust Company, as warrant agent, and EQRx, Inc.
RVMD 10-Kaccession 0001193125-26-071563
SentenceFollowing the EQRx Acquisition, the warrants became exercisable for shares of our common stock, and we appointed Equiniti Trust Company, LLC as the warrant agent.
RVMD 10-Kaccession 0001193125-26-071563
SentenceIn May 2025, we entered into a collaboration with Iambic Therapeutics (Iambic), pursuant to which Iambic uses its artificial intelligence capabilities to generate customized models through training with our proprietary data.
RVMD 10-Kaccession 0001193125-26-071563
SentencePursuant to the Royalty Purchase Agreement, in exchange for an upfront payment of $250.0 million, Royalty Pharma purchased from us the right to receive royalty payments with respect to worldwide net product sales in a calendar year (Annual Net Sales) of (a) RMC-6236 Products and (b) RMC-9805 Products, if an RMC-9805 Product is approved for the same indication or subset of the same indication for which an RMC-6236 Product is approved.
The Sanofi Agreement was terminated in June 2023, and Sanofi has no further reimbursement obligations following this termination.
Linked news
Expected move
Inputsstraddle ±10.4%
spot 191.31exp Nov 20ATM strike 190ATM straddle 23.30IV 64%